Felix Theeuwes
Keine laufenden Positionen mehr
Profil
Felix Theeuwes is the founder of DURECT Corp., which was founded in 1998.
He held the title of Chairman in 2018.
Dr. Theeuwes also held former positions as a Director at Genetronics Biomedical Corp.
and Inovio Pharmaceuticals, Inc. He was the President-New Ventures at ALZA Corp.
from 1982 to 1998.
Dr. Theeuwes received his undergraduate and graduate degrees from Katholieke Universiteit Leuven.
He also received a doctorate from Katholieke Universiteit Leuven in 1966.
Ehemalige bekannte Positionen von Felix Theeuwes
| Unternehmen | Position | Ende |
|---|---|---|
| DURECT CORPORATION | Gründer | 31.12.2018 |
| INOVIO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 04.05.2007 |
| Genetronics Biomedical Corp. | Direktor/Vorstandsmitglied | 05.04.2005 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.08.1998 |
Ausbildung von Felix Theeuwes
| Katholieke Universiteit Leuven | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DURECT CORPORATION | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Genetronics Biomedical Corp. | Commercial Services |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
